Vincent P. Ippolito, EVP & Chief Commercial Officer at Anacor Pharmaceuticals, Inc. (ANAC), sold 20,000 shares at $108.22 ($2.2M) on 2015-12-09, disclosed to the SEC on 2015-12-11.
Scheduled sale ($2.2M) by EVP & Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $107.85 | 17,270 | $1.9M | 86.3% |
| 2 | $108.22 | 2,730 | $295K | 13.7% |
| Total | $107.90 avg | 20,000 | $2.2M | 100% |
| Filing → |
| ANAC | SELL | 2016-01-05 | $181K | — | Filing → |
| ANAC | SELL | 2015-03-04 | $395K | — | Filing → |
| MRX | SELL | 2011-05-17 | $4.2M | — | Filing → |